30
Views
9
CrossRef citations to date
0
Altmetric
Review

Targeted mucosal delivery of drugs and vaccines

Pages 179-190 | Published online: 25 Feb 2005

Bibliography

  • DAVIS SS: Further developments in nasal drug delivery. PST7' (1999) 2(7):265–266.
  • DOUCE G, GIANNELLI V, PIZZA MG et al: Genetically detoxified mutants of heat labile toxins from Escheri-chia coli are able to act as oral adjuvants. Infect. Immun (1999) 67:4400–4406.
  • •Recent paper describing the efficacy of genetically toxoided mutants of E. coil heat labile toxin as oral and intranasal adjuvants.
  • SCHIPPER NGM, VERHOEF JC, MERKUS FWHM: The nasal mucociliary clearance: Relevance to nasal drug delivery. Pharm. Res. (1991) 8:807–814.
  • •Difficulties posed to nasal drug delivery by mucociliary clearance.
  • WITSCHI C, MRSNY RJ: In vitro evaluation of micropar- tides and polymer gels for use as nasal platforms for protein delivery. Pharm. Res. (1999) 16:382–390.
  • •Potential of bioadhesive systems for nasal drug delivery.
  • WYATT TL, WHALEY KJ, CONE RA, SALZMAN WM: Antigen-releasing polymer rings and microspheres stimulate mucosal immunity in the vagina. J. Control Release (1998) 50:93–102.
  • YU JW, CHIEN YW: Pulmonary drug delivery: physiol-ogic and mechanistic aspects. Grit. Rev. Ther. Drug Carrier Syst. (1997) 14:395–453.
  • •Comprehensive review of pulmonary drug delivery.
  • HAN RY, FANG JY, SUNG KC, HU OYP: Mucoadhesive buccal discs for novel nalbuphine prodrug controlled delivery: effect of formulation variables on drug release and mucoadhesive performance. Int. J. Pharm 177:201–209.
  • CHEN GH, HOFFMAN AS, KABRA B, RANDERI K: Temperature-induced gelation pluronic-g-poly (acrylic acid) graft copolymers for prolonged drug delivery to the eye. A CS Symp. Series (1997) 680:441–457.
  • •Ocular drug delivery using a bioadhesive polymeric system.
  • OWEN RL, ERMAK TH: Structural specialisations for antigen uptake and processing in the digestive tract. Spring. Sem. Immunopathol (1990) 12:139–152.
  • LEE VHL, YAMAMOTO A: Penetration and enzymatic barriers to peptide absorption. Adv. Drug. Deliv. Rev. (1990) 4:171–207.
  • NEUTRA MR, KRAEHENBUHL J-P: Antigen uptake by M cells for effective mucosal vaccines. In: Mucosa] Vaccines. Kiyono H, Ogra PL, McGhee JR. (Eds), Academic Press, London (1996):41–55.
  • FREY A, GIANNASCA KT, WELTZIN R et al.: Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: Implications for microbial attachment and oral vaccine targeting. J. Exp. Med. (1996) 184:1045–1059.
  • ••Important paper demonstrating the barrier presented toparticulate delivery systems by the glycocalyx.
  • O'HAGAN DT: Microparticles as oral vaccines. In: Novel Deliver)/Systems for Oral Vaccines. O'Hagan DT (Ed.), CRC Press, Boca Raton, Florida (1994):175–205.
  • BRANDTZAEG P, FARSTAD IN, HARALDSEN G: Regional specialization in the mucosal immune system: primed cells do not always home along the same track. Immunol. Today (1999) 20:267–277.
  • •Recent review of the mucosal immune system focusing on compartmentalisation.
  • CHALLACOMBE SJ, RAHMAN D, JEFFERY H, DAVIS SS, O'HAGAN DT: Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology (1992) 76:164–168.
  • •Early paper showing the efficacy of polymer microparticles as oral vaccine delivery systems.
  • GIANNASCA PJ, GIANNASCA KT, FALK P, GORDON JI, NEUTRA MR: Regional differences in glycoconjugates of intestinal M cells in mice: potential targets for mucosal vaccines. Am. J. Physiol (1994) 267:G1108–G1121.
  • •Identification of M cell-specific lectins in the mouse intestine.
  • JIMÉNEZ-CASTELLANOS M R, ZIA H, RHODES CT: Mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm. (1993) 19:143–194.
  • DAVIS SS, HARDY JG, FARA JW: Transit of pharmaceu-tical dosage forms through the small intestine. Gut (1986) 27:886–892.
  • •A demonstration of the rapid gut transit in humans.
  • LEHR C-M, BOUWSTRA JA, KOK W, NOACH ABJ, DE BOERAG, JUNGINGER HE: Bioadhesion by means of specific binding of tomato lectin. Pharm. Res. (1992) 9:547–553.
  • NAGAI T: Adhesive drug delivery system. J. Control.Release (1985) 2:121–134.
  • FRISBIE CD, ROZSNYAI LF, NOY A, WRIGHTON MS, LIEBER CM: Functional-group imaging by chemical force microscopy. Science (1994) 265:2071–2074.
  • INOUE T, CHEN GH, HOFFMAN AS, NAKAMAE K: A hydrophobically modified bioadhesive polymeric carrier for controlled drug delivery to mucosal surfaces. J. BioacL CompaL Polymers (1998) 13:50–64.
  • MATHIOWITZ E, JACOB JS, JONG YS et al.: Biologicallyerodible microspheres as potential oral drug delivery systems. Nature (1997) 386:410–414.
  • •Promising results using orally delivered bioadhesive polymeric microspheres.
  • BERNKOP-SCHNURCH A, SCHVVARZ V, STEININGER S: Polymers with thiol groups: a new generation of mucoadhesive polymers? Pharm. Res. (1999) 16:876–881.
  • LEHR C-M: Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract. Crit. Rev. Ther. Drug Carrier Syst. (1994) 11:119–160.
  • JEPSON MA, SIMMONS NL, O'HAGAN DT, HIRST BH: Comparison of poly (dl - lactide - co - glycolide) and polystyrene microsphere targeting to intestinal M cells. J. Drug Target (1993) 1:245–249.
  • •A study showing that the surface characteristics of microspheres influence the degree of binding to Peyer's patch M cells in mice.
  • PEUMANS WJ, VAN DAMME EJM: Lectins as plant defense proteins. Plant Physic)]. (1995) 109:347–352.
  • NACHBAR MS, OPPENHEIM JD: Lectins in the United States diet: a survey of lectins in commonly consumed foods and a review of the literature. Am. J. Clin. Nutr. (1980) 33:2338–2345.
  • PUSZTAI A, BARDOCZ, S: Biological effects of plant lectins on the gastrointestinal tract: metabolic consequences and applications. Trends Glycosci. Glycotechnol (1996) 8:149–165.
  • LEHR C-M, PUSZTAI A: The potential of bioadhesive lectins for the delivery of peptide and protein drugs to the gastrointestinal tract. In: Lectins: Biomedical perspec-tives. Pusztai A, Bardocz S (Eds.), Taylor and Francis, London, UK (1995):117–140.
  • WIRTH M, HAMILTON G, GABOR F: Lectin-mediated drug targeting: quantification of binding and internali-sation of wheatgerm agglutinin and Solanum tuberosum lectin using Caco-2 and HT-29 cells. J. Drug Target (1998) 6:95–106.
  • GABOR F, STANGL M, WIRTH M: Lectin-mediatedbioadhesion: binding characteristics of plant lectins on the enterocyte-like cell lines Caco-2, HT-29 and HCT-8. J. Control Release (1998) 55:131–142.
  • KILPATRICK DC, PUSZTAI A, GRANT G, GRAHAM C, EWEN SWB: Tomato lectin resists digestion in the mammalian alimentary canal and binds to intestinal villi without deleterious effects. FEBS Lett. (1985) 185:2299–305.
  • NICHOLLS TJ, GREEN KL, ROGERS DJ, COOK JD, WOLOWACZ S, SMART JD: Lectins in ocular drug delivery: an investigation of lectin binding sites on the cornea and conjunctival surfaces. Int. J. Pharm. (1996) 138:175–183.
  • •An investigation into lectins in ocular drug delivery.
  • SINGH RS, TIWARY AK, KENNEDY JF: Lectins: sources, activities, and applications. Grit. Rev. Biotechnol (1999) 19:145–178.
  • CLARK MA, JEPSON MA, SIMMONS NL, BOOTH TA, HIRST BH: Differential expression of lectin binding sites defines mouse intestinal M-cells. J. Histochem. Cytochem. (1993) 41:1679–1687.
  • •Significant publication showing that mouse M cells express distinct glycoconjugates which may be targeted using plant lectins.
  • SHARMA R, VAN DAMME EJM, PEUMANS WJ, SARSFIELD, SCHUMACHER U: Lectin binding reveals divergent carbohydrate expression in human and mouse Peyer's patches. Histochem. Cell Biol. (1996) 105:459–465.
  • •A demonstration of considerable differences in binding of lectins to Peyer's patch M cells in mice and humans.
  • CLARK MA, JEPSON MA, HIRST BH: Lectin binding defines and differentiates M-cells in mouse small intestine and caecum. Histochem. Cell Biol. (1995) 104:161–168.
  • JEPSON MA, CLARK MA, FOSTER N et al: Targeting to intestinal M cells. J. Anat. (1996) 189:507–516.
  • •Concise review of work on binding of lectins to M cells
  • WANG Q, YU L-G, CAMPBELL BJ, MILTON JD, RHODES JM: Identification of intact peanut lectin in peripheral venous blood. Lancet (1998) 352:1831–1832.
  • •A demonstration of the uptake of an ingested plant lectin in humans.
  • CLARK MA, JEPSON MA, SIMMONS NL, HIRST BH: Selective binding and transcytosis of Ulex europaeus I lectin by mouse Peyer's patch M cells in vivo. Cell Tissue Res. (1995) 282:455–461.
  • ••Evidence for translocation of the lectin UEA I followingbinding to mouse M cells.
  • KING TP, PUSZTAI A, GRANT G, SLATER D: Immunogold localization of ingested kidney bean (Phaseolus vulgaris) lectins in epithelial cells of the rat small intestine. Histochem. J. (1986) 18:413–420.
  • •Evidence that PHA is taken up following binding to the small intestine of rats.
  • GIANNASCA PJ, BODEN JA, MONATH TP: Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell directed lectins. Infect. Immun. (1997) 65:4288–4298.
  • ••Identification of lectins which bind to M cells of hamsternasal-associated lymphoid tissue.
  • DE AIZPURUA HD, RUSSELL-JONES GL: Identification of classes of proteins that provide an immune response upon oral feeding. J. Exp. Med. (1988) 167:440–451.
  • ••Important early publication demonstrating the immunogen-icity and carrier potential of bacterial and plant lectins.
  • BROADWELL RD, BALIN BJ, SALEMAN M: Transcytotic pathway for blood-borne protein through the blood-brain barrier. Proc. Natl. Acad. Sci. USA (1988) 85:632–636.
  • •Possibility of using lectins to direct transport across the blood-brain barrier.
  • NAISBETT B, WOODLEY J: The potential use of tomato lectin for oral drug delivery: 4. Immunological consequences. Int. J. Pharm. (1995) 120:247–254.
  • LAVELLE EC, SHARIF S, THOMAS NW, HOLLAND J, DAVIS SS: The importance of gastrointestinal uptake of particles in the design of oral delivery systems. Adv. Drug Deliv. Rev. (1995) 18:5–22.
  • RUSSELL-JONES GJ: The potential use of receptor- mediated endocytosis for oral drug delivery. Adv. Drug Delhi. Rev. (1996) 20:83–97.
  • •Comprehensive review of the potential of receptor-mediated endocytosis pathways to facilitate uptake of orally administered drugs.
  • CARRENOGOMEZ B, WOODLEY JF, FLORENCE AT: Studies on the uptake of tomato lectin nanoparticles in everted gut sacs. Int. J. Pharm. (1999) 183:7–11.
  • CHEN H, TORCHILLIN V, LANGER R: Lectin-bearing polymerized liposomes as potential oral vaccine carriers. Pharm. Res. (1996) 13:1378–1382.
  • •Use of plant lectins to target liposomes to Peyer's patches.
  • BATRA RK, WANG-JOHANNING F, WAGNER E, GARVER JR RI, CURIEL DT: Receptor-mediated gene delivery employing lectin-binding specificity. Gene Ther. (1994) 1:255–260.
  • •Application of a plant lectin for gene delivery.
  • HABBERFIELD A, JENSEN-PIPPO K, LLOYD R, WESTWOOD SW, RUSSELL-JONES GJ: Vitamin B12-mediated uptake of erythropoietin and granulo-cyte colony stimulating factor in vitro and in vivo. Int. J. Pharm. (1996) 145:1–8.
  • GRUTZKAU A, HANSKI C, HAHN H, RIECKEN EO: Involvement of M cells in the bacterial invasion of Peyer's patches: a common mechanism shared by Yersinia enterocolitica and other enteroinvasive bacteria. Gut (1990) 3:1011–1015.
  • •Interactions of gut pathogens with M cells.
  • DUGUID JP, GILLIES RR: Fimbriae and adhesive proper- ties in dysenteric bacilli. J. Pathol. Bacteriol (1957) 74:397–411.
  • DUGUID JP, ANDERSON ES, CAMPBELL I: Fimbriae and adhesive properties in Salmonellae. J. Pathol. Bacteriol (1966) 92:107–138.
  • BRENNAN MJ, SHAHIN RD: Pertussis antigens that abrogate bacterial adherence and elicit immunity. Am. Resp. Grit. Care Med. (1996) 154:S145–S149.
  • RUBAS W, BANERIEA AC, GALLATI H, SPEISER PP, JOKLIK WK: Incorporation of the reovirus M-cell attachment protein into small unilamellar vesicles: incorporation efficacy and binding capacity to L929 cells in vitro. J. Microencapsul (1990) 7:385–395.
  • OWEN RL, BASS DM, PIAZZA AJ: Colonic lymphoid patches. A portal of entry in mice for Type 1 reovirus administered anally. Gastroenterology (1990) 98:A468.
  • MORIN MJ, WARNER A, FIELDS BN: A pathway for entry of reoviruses into the host through M cells of the respiratory tract. J. Exp. Med. (1994) 180:1523–1527.
  • RAVDIN JI, SHAIN DC, KELSALL B: Antigenicity, immunogenicity and vaccine efficacy of the galactose-specific adherence protein of Entamoeba histolytica. Vaccine (1993) 11:241–246.
  • OSUNA A, RODR1GUEZ-CABEZAS M N, CASTANYS S, MESA-VALLE MC, MASCARO MC: A protein secreted by Trypanosoma cruzi capable of inducing the entry of inert particles into HeLa cells. Int. J. Parasitol (1995) 25:1213–1225.
  • •A parasite-derived protein can facilitate entry of inert particles into tissue culture cells.
  • GABOR F, BERNKOP-SCHNeRCH A, HAMILTON G: Bioadhesion to the intestine by means of E. coli K99-fimbriae: gastrointestinal stability and specificity of adherence. Eur. J. Pharm. Sci. (1997) 5:233–242.
  • CASTON AJ, DAVIS SS, WILLIAMS P: The potential of fimbrial proteins for delaying intestinal transit of oral drug delivery systems. Proc. Int. Symp. Control. Rel. Bioact. Mater. (1990) 17:313–314.
  • ISBERG RR: Discrimination between intracellularuptake and surface adhesion of bacterial pathogens. Science (1991) 252:934–938.
  • FRANKEL G, CANDY DCA, EVEREST P, DOUGAN G: Characterization of the C-terminal domains of intimin-like proteins of enteropathogenic and entero-hemorrhagic proteins of Escherichia coli, Citrobacter freundii, and Hafnia alvei. Infect. Immun. (1994) 62:1835–1842.
  • HUSSAIN N, FLORENCE AT: Utilising bacterialmechanisms of epithelial cell entry: invasin-induced oral uptake of latex nanoparticles. Pharm. Res. (1998) 15:153–156.
  • JENKINS PG: Mucosal vaccine delivery. Exp. Opin. Ther.Patents (1999) 9:255–262.
  • BERGMANN K-C, WALDMAN RH, BICAK M, RUSSELL-JONES GJ: Adjuvant effect of B-subunit of E. coli heat-labile toxin on secretory antibody response to oral influenza virus immunization in mice. Allergologie (1989) 12:294.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.